Nan Wang

发表

Apaf‐1 interacting protein, a new target of microRNA‐146a‐3p, promotes prostate cancer cell development via the ERK1/2 pathway

Shan Jiang, P. Lin, Xiaoguang Yu, 2022, Cell biology international.

LncRNA AC245100.4 affects the tumorigenesis of prostate cancer via regulating the STAT3/NR4A3 axis

Shan Jiang, Q. Qi, P. Lin, 2020 .

Dosage and Temporal Thresholds in microRNA Proteomics*

N. Ahn, W. Old, S. Houel, 2014, Molecular & Cellular Proteomics.

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Yi-Hsuan Ho, J. Lunec, P. Lovat, 2017, British Journal of Cancer.

Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/NR4A3 axis.

Shan Jiang, P. Lin, Xiaoguang Yu, 2021, Epigenomics.

A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells*

Nan Wang, Natalie G. Ahn, William M. Old, 2015, Molecular & Cellular Proteomics.

Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of Trastuzumab plus Pertuzumab.

M. Dong, Tong Liu, Nan Wang, 2023, Immunopharmacology and immunotoxicology.

Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway

P. Lin, Xiaoguang Yu, Nan Wang, 2022, Medical Oncology.

GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway.

Shan Jiang, P. Lin, Xiaoguang Yu, 2021, Biochemical and biophysical research communications.